Interleukin-2 Therapy for HIV Infection - Supplemental Procedures
NCT00001354
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
NIH
Sponsor class
Conditions
Acquired Immunodeficiency Syndrome
HIV Infection
Interventions
DRUG:
Interleukin-2/Zidovudine (AZT)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)